Postdoctoral position in "Systematic Reviews and Meta-Analysis" related to infectious diseases and vaccination
Applications are invited for a postdoctoral position with expertise and experience in "Systematic Reviews and Meta-Analysis" related to infectious diseases and vaccination. Applicants whose academic profile fit the following requirements are welcomed to apply and send their application materials to abmlab@yorku.ca
- A PhD in mathematical/statistical sciences, public health, epidemiology, or relevant fields to infectious disease modelling, immunization, and public health
- Within 4 years of PhD degree
- Interested in interdisciplinary projects and able to lead research projects within expected timelines
- Evidence of research related to systematic reviews and meta-analysis (e.g., publications in high impact journals); fluency in search and meta-analysis software and pooled analysis
- Available to start the PDF as soon as possible, and preferably before/by April 1, 2023.
Salary will commensurate with experience and expertise in the range of $48,000 to $54,000 (Canadian) + 10.5% benefits. For applicants who chose the US location of Yale University as their base, salary will be adjusted accordingly.
Location: ABM-Lab at York University, Toronto, Canada
https://abm-lab.yorku.ca/
Collaboration (or possible location of PDF): Yale School of Public Health
Application documents:
- Cover letter, indicating the interest, and how their experience and expertise fit the position
- At least one sample publication related to subject of systematic review and meta-analysis
- At least one strong recommendation letter, sent directly to abmlab@yorku.ca
- CV
Applications will be reviewed as they arrive; incomplete applications (missing above documents) will not be considered.
- Type
- Postdoc
- Institution
- York University (Canada) or Yale University (USA)
- City
- Toronto or New Haven
- Country
- Canada or US
- Closing date
- May 1st, 2023
- Posted on
- January 18th, 2023 19:05
- Last updated
- January 18th, 2023 19:05
- Share
- Tweet